MEDICINOVA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
MEDICINOVA, INC. (MNOV) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $3.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-03-10
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $3.00K.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $500.00K.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-12-31 | $3.00K 10-K · filed 2026-03-10 |
| 2024-12-31 | $500.00K 10-K · filed 2026-03-10 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-19 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-15 |
| 2021-12-31 | $32.84K 10-K/A · filed 2023-03-28 |
| 2020-12-31 | $5.70M 10-K · filed 2022-02-16 |
| 2019-12-31 | $11.80M 10-K · filed 2021-02-19 |
| 2018-12-31 | $23.60M 10-K · filed 2020-02-13 |
| 2017-12-31 | $13.60M 10-K · filed 2019-02-13 |
| 2016-12-31 | $11.50M 10-K · filed 2018-02-13 |
| 2016-09-30 | $17.80M 10-Q · filed 2016-10-25 |
| 2016-06-30 | $18.13M 10-Q · filed 2016-07-26 |
| 2016-03-31 | $17.27M 10-Q · filed 2016-04-27 |
| 2015-12-31 | $1.90M 10-K · filed 2017-02-14 |
| 2015-09-30 | $450.68K 10-Q · filed 2015-10-29 |
| 2015-06-30 | $2.88M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $1.81M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $800.28K 10-K · filed 2015-03-12 |
| 2014-09-30 | $726.73K 10-Q · filed 2014-11-13 |
| 2013-12-31 | $144.00 10-K · filed 2014-03-27 |
| 2013-09-30 | $132.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $209.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $276.00K 10-Q · filed 2013-05-08 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |